(Total Views: 263)
Posted On: 05/20/2021 8:09:39 AM
Post# of 36541
Hey Buildit.
The agreements, call for them(Bintai/China etc) to pay for the trials, but we pay for the manufacturing, fill/finish etc. Also the variants were not around back then so we have to pay for that part of the research.
Perhaps if things go well on the vaccine Bintai will reconsider the variants or another pharma could partner with us. Could be a good thing the agreement did not address the variants. Just a thought.
The agreements, call for them(Bintai/China etc) to pay for the trials, but we pay for the manufacturing, fill/finish etc. Also the variants were not around back then so we have to pay for that part of the research.
Perhaps if things go well on the vaccine Bintai will reconsider the variants or another pharma could partner with us. Could be a good thing the agreement did not address the variants. Just a thought.
(1)
(0)Scroll down for more posts ▼
